Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› KLKB1
KLKB1
(1 companies · 1 programs)
Companies with an active program directed at KLKB1.
Intellia Therapeutics, Inc.
NTLA
lonvoguran ziclumeran
— Hereditary Angioedema
NDA Submitted